AI-generated summary
The authors randomized 24 healthy volunteers to control, placebo, or LIMIRT treatment (840 nm light) after inducing muscle soreness in the biceps brachii. Compared with controls, the treatment group had significantly lower pain and tenderness scores, but treatment did not differ significantly from placebo on most measures. The authors concluded that LIMIRT was ineffective for delayed onset muscle soreness at the parameters studied.
- Participants
- 24
- Who or what was studied
- Healthy volunteers (12 male, 12 female) with experimentally induced delayed onset muscle soreness in the biceps brachii
- Wavelengths
- 840 nm
- Limits stated in the abstract
- The abstract describes the study as preliminary and reports that most comparisons against placebo were not statistically significant.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on onlinelibrary.wiley.com.
Record from PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Wavelength
- 840 nm
- Total energy
- 3.0 J
How to read a trial: what to check before relying on this kind of research.
Terms in this paper: Delayed onset muscle soreness. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.